EDGAR Filing Documents for 0001104659-16-121886

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001104659-16-121886

Filing Date

2016-05-18

Accepted

2016-05-18 16:52:04

Documents

Period of Report

2016-05-11

Document Format Files

Seq	Description	Document	Type	Size
1	3	a3.html	3
1	3	a3.xml	3	8644
	Complete submission text file	0001104659-16-121886.txt		11959

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104

Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 161661030

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104

Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211

Versant Venture Capital IV, L.P. (Reporting) CIK: 0001456590 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 161661029

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025

Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269

Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051

Business Address AESCHENVORSTADT 36 BASEL V8 4051 (415) 801-8100

Versant Capital IV (Switzerland) GmbH (Reporting) CIK: 0001674481 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 161661027

Mailing Address 5, RUE GUILLAUME KROLL LUXEMBOURG N4 L-1882

Business Address 5, RUE GUILLAUME KROLL LUXEMBOURG N4 L-1882 (415) 801-8100

State of Incorp.: N4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 161661028